Skip Navigation
Skip to contents
Filter

ARTICLE TYPE

PUBLICATION DATE

10 results
Display

Pediatric liver transplantation using a hepatitis B surface antigen-positive donor liver graft for congenital absence of the portal vein

Namgoong JM, Hwang S, Kim DY, Ha TY, Song GW, Jung DH, Kim KM, Oh SH

Congenital absence of the portal vein (CAPV) is a rare venous malformation in which mesenteric venous blood drains directly into systemic circulation. Herein, we report a case of pediatric deceased...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Early use of everolimus improved renal function after adult deceased donor liver transplantation

Lee S, Kim JM, Kim S, Rhu J, Choi GS, Joh JW

Background: Tacrolimus (TAC) is a main therapy for liver transplantation (LT) patients, but it has side effects such as chronic nephrotoxicity that progressively aggravate renal function. The purpose of this...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Posttransplantation tuberculosis management in terms of immunosuppressant cost: a case report in Myanmar

Lwin PW, Htun YY, Myint AK, Swe HK

Drug interactions between anti-tuberculosis and immunosuppressive medications after renal transplantation are a common problem in Myanmar. The efficacy of both types of drugs can be reduced during the treatment period,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Acute antibody-mediated rejection limited to medullary lesions in following ABO-incompatible living donor kidney transplantation

Kim AY, Cho KH, Park JW, Do JY, Han MH, Kim YJ, Kang SH

Anatomical differences between the renal cortex and medulla may influence inflammatory responses. Owing to the difficulty in diagnosing rejections from the medulla, rejection is usually diagnosed through the cortex. However,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The impact of prophylactic ureteral stenting during kidney transplantation on postoperative surgical outcomes

Park J, Lee SY, Lee HS, Shin SK, Kim TH

Background: The aim of this study was to evaluate the safety and feasibility of prophylactic ureteric stenting during kidney transplantation (KT). Methods: The authors retrospectively reviewed patients who underwent KT between...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Pediatric split liver transplantation for congenital factor X deficiency: first 10-year follow-up of a case with portal vein stenting

Namgoong JM, Hwang S, Kim DY, Ha TY, Song GW, Dong-Hwan DH, Kim KM, Oh SH

Congenital factor X (FX) deficiency is a rare autosomal-recessive disease that induces bleeding disorder. Herein, we present the 10-year posttransplant course of a pediatric patient who underwent liver transplantation (LT)...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Outcome of patients with severe alcoholic hepatitis after Model for End-Stage Liver Disease-based allocation system implementation in Korea

Kwon TJ, Kang W, Gwak GY, Paik YH, Choi MS, Lee JH, Koh KC, Sinn DH, Paik SW

Background: The Model for End-Stage Liver Disease (MELD)-based allocation system was implemented in Korea in July 2016 without a mandatory abstinence period for liver transplantation (LT) listing. However, the impact...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Comparison of single nucleotide polymorphisms and short tandem repeats as markers for differentiating between donors and recipients in solid organ transplantation

Lee HJ, Shin KH, Jeong SJ, Kim IS

Background: To analyze transplant rejection and to distinguish between donor and recipient, it is necessary to select a marker from single nucleotide polymorphism (SNP), short tandem repeat (STR), and human...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Clinical significance of de novo donor-specific antibody in kidney transplant recipients with chronic antibody-mediated rejection

Park WY, Kim Y, Paek JH, Jin K, Han S

Background: Chronic antibody-mediated rejection (CABMR) is an important cause of late graft loss. De novo donor-specific antibody (dnDSA) is an important prognostic factor for long-term allograft outcomes. However, the prognosis...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Prognosis of hepatic epithelioid hemangioendothelioma after living donor liver transplantation

Na BG, Hwang S, Ahn CS, Kim KH, Moon DB, Ha TY, Song GW, Jung DH, Park GC, Yoon YI, Kang WH, Cho HD, Kim SH, Hong SM, Lee SG

Background: Epithelioid hemangioendothelioma (EHE) is a rare borderline vascular tumor. Due to its rarity and protean behavior, the optimal treatment of hepatic EHE has not yet been standardized. This single-center...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr